Y-mAbs Therapeutics, Inc.: cashflow_operating
| Value | {"amount": -19196000, "concept": "us-gaap:NetCashProvidedByUsedInOperatingActivities", "currency": "USD"} |
|---|---|
| Period | 2023-01-01 – 2023-09-30 |
| Status | current |
| Entity | Y-mAbs Therapeutics, Inc. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T17:37:23.958445+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/1a71c4cb-22dc-46d3-b318-68fde40f6bf2
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001558370-23-018827Retrieved: 2026-08-19T17:37:23.958445+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001722964/cashflow-operating/2023-09-30 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/1a71c4cb-22dc-46d3-b318-68fde40f6bf2
History
- no predecessors — first report